RXRX earnings

Catalyst

RXRX earnings

RXRX earnings — 2026-08-05

Reported the quarter ending 2026-06-30: revenue $8M, diluted EPS -$0.25, net income -$131M (SEC filing). Across the print the stock moved -3.9% (close before → first close after).

Backfilled from filed financials — a record of the print, not an analyst read.

Sources

  • Financials: edgar
  • Price reaction: ohlc
10 events
DateTypeEvent
Aug 8 ScanBiotech Scan Jul 31 ScanBiotech Scan Jul 28 ScanBiotech Scan Aug 14 ScanBiotech Scan Jul 25 ScanBiotech Scan Aug 19 ScanWashout Turn Scan Aug 20 ScanWashout Turn Scan Aug 21 ScanWashout Turn Scan Aug 22 ScanWashout Turn Scan Aug 22 ScanBiotech Scan

No direct external sources are attached to this read.